The dysregulation of oncoproteins E6 and E7 can lead to the development of cancer, and the E6 protein causes the loss of activity of p53 by promoting its degradation, while E7 causes the loss of cell cycle control by binding to the cyclin-dependent kinase inhibitor [13]. The gene discussed is TP53; the disease is cancer.